SCHEMBL3195486

SCHEMBL3195486

[2H]C([2H])([2H])C([2H])([2H])OC(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29544863 0.78
SCHEMBL3195509 0.76
Ethyl Acetate SCHEMBL1330912 0.74
SCHEMBL12998279 0.72
Urethane SCHEMBL10825610 0.70
SCHEMBL3802558 0.69
SCHEMBL12998276 0.66 CYP4F2 (0.35)
SCHEMBL342 0.65
SCHEMBL27838562 0.65 ALDH1A1 (0.56)
SCHEMBL9723666 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11858900-B2 Fluorinated 2-amino-4-(substituted amino)phenyl carbamate derivatives OCUTERRA THERAPEUTICS, INC. (US) 2024-01-02 US disclosed
US-20100029716-A1 NOVEL 1,2,3,4- TETRAHYDROQUINOLINE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2010-02-04 US disclosed
WO-2007120621-A2 NONEL 1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES CONCERT PHARMACEUTICALS, INC. (US) 2007-10-25 WO disclosed